Recent reports indicate that drug shortages persist in being a significant public health threat.
Decades have come and gone, healthcare and science have become more effective and sophisticated, yet outcomes for black women have hardly budged.
The draft tax reform proposal would eliminate incentives for drug manufacturers to develop therapies to treat and cure the more than 7,000 rare diseases afflicting more than 30 million Americans.
The market restrictions that the Food and Drug Administration (FDA) places on assistive listening devices have remained mostly unchanged since the late 1970s.
Some of its members of the Dietary Guidelines Advisory Committee seem much more focused on pursuing their own environmental agendas than educating American consumers on nutrition.
Wouldn’t it make sense to ensure that Medicare patients have 24/7 access to high functioning primary care so that they won’t be forced into ERs and hospitals unnecessarily?
Poor service to veterans, which has led to massive backlogs for benefits and medical appointments and a rash of preventable deaths, has become VA’s calling card.
The World Health Organization estimates that upwards of 30 percent of the drug supply in some developing nations is counterfeit.
America’s injured veterans face their next daunting challenge: getting what they deserve when they come home.
Unlike a mortgage, a car payment or credit card bill, it’s impossible to fully plan for sickness or the costs associated with often expensive treatments.